Rapin I, Lindenbaum Y, Dickson D W, Kraemer K H, Robbins J H
Department of Neurology, Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine,Bronx, NY, USA.
Neurology. 2000 Nov 28;55(10):1442-9. doi: 10.1212/wnl.55.10.1442.
To review genetic variants of Cockayne syndrome (CS) and xeroderma pigmentosum (XP), autosomal recessive disorders of DNA repair that affect the nervous system, and to illustrate them by the first case of xeroderma pigmentosum-Cockayne syndrome (XP-CS) complex to undergo neuropathologic examination.
Published reports of clinical, pathologic, and molecular studies of CS, XP neurologic disease, and the XP-CS complex were reviewed, and a ninth case of XP-CS is summarized.
CS is a multisystem disorder that causes both profound growth failure of the soma and brain and progressive cachexia, retinal, cochlear, and neurologic degeneration, with a leukodystrophy and demyelinating neuropathy without an increase in cancer. XP presents as extreme photosensitivity of the skin and eyes with a 1000-fold increased frequency of cutaneous basal and squamous cell carcinomas and melanomas and a small increase in nervous system neoplasms. Some 20% of patients with XP incur progressive degeneration of previously normally developed neurons resulting in cortical, basal ganglia, cerebellar, and spinal atrophy, cochlear degeneration, and a mixed distal axonal neuropathy. Cultured cells from patients with CS or XP are hypersensitive to killing by ultraviolet (UV) radiation. Both CS and most XP cells have defective DNA nucleotide excision repair of actively transcribing genes; in addition, XP cells have defective repair of the global genome. There are two complementation groups in CS and seven in XP. Patients with the XP-CS complex fall into three XP complementation groups. Despite their XP genotype, six of nine individuals with the XP-CS complex, including the boy we followed up to his death at age 6, had the typical clinically and pathologically severe CS phenotype. Cultured skin and blood cells had extreme sensitivity to killing by UV radiation, DNA repair was severely deficient, post-UV unscheduled DNA synthesis was reduced to less than 5%, and post-UV plasmid mutation frequency was increased.
The paradoxical lack of parallelism of phenotype to genotype is unexplained in these disorders. Perhaps diverse mutations responsible for UV sensitivity and deficient DNA repair may also produce profound failure of brain and somatic growth, progressive cachexia and premature aging, and tissue-selective neurologic deterioration by their roles in regulation of transcription and repair of endogenous oxidative DNA damage.
回顾科凯恩综合征(CS)和着色性干皮病(XP)的基因变异,这两种常染色体隐性DNA修复障碍疾病会影响神经系统,并通过首例接受神经病理学检查的着色性干皮病 - 科凯恩综合征(XP - CS)复合体病例进行说明。
回顾了已发表的关于CS、XP神经系统疾病以及XP - CS复合体的临床、病理和分子研究报告,并总结了第9例XP - CS病例。
CS是一种多系统疾病,会导致躯体和脑部严重生长发育迟缓以及进行性恶病质、视网膜、耳蜗和神经变性,伴有脑白质营养不良和脱髓鞘性神经病变,且癌症发病率无增加。XP表现为皮肤和眼睛对光极度敏感,皮肤基底细胞癌、鳞状细胞癌和黑色素瘤的发病频率增加1000倍,神经系统肿瘤发病率略有增加。约20%的XP患者会出现先前正常发育的神经元进行性变性,导致皮质、基底神经节、小脑和脊髓萎缩、耳蜗变性以及混合性远端轴索性神经病变。CS或XP患者的培养细胞对紫外线(UV)辐射杀伤高度敏感。CS和大多数XP细胞在活跃转录基因的DNA核苷酸切除修复方面存在缺陷;此外,XP细胞在全基因组修复方面存在缺陷。CS有两个互补组,XP有七个互补组。XP - CS复合体患者分为三个XP互补组。尽管具有XP基因型,但9例XP - CS复合体患者中有6例,包括我们随访至6岁死亡的男孩,具有典型的临床和病理严重CS表型。培养的皮肤和血细胞对UV辐射杀伤极度敏感,DNA修复严重缺陷,UV后非预定DNA合成减少至低于5%,UV后质粒突变频率增加。
在这些疾病中,表型与基因型缺乏平行性这一矛盾现象尚无法解释。也许导致UV敏感性和DNA修复缺陷的多种突变,也可能通过其在调节转录和修复内源性氧化DNA损伤中的作用,导致脑和躯体生长严重衰竭、进行性恶病质和早衰以及组织选择性神经退化。